Hefez L, Micallef J, Revah-Levy A, et al. - A random sample of dermatologists treating adolescents conducted a national, multicentric prospective study investigating the acceptability of the ADRS (Adolescent Depression Rating Scale) for monitoring mental health symptoms among adolescents before and during isotretinoin treatment in dermatology real-life practice.

• The algorithm was used by a total of 70 dermatologists among 283 adolescents receiving isotretinoin during 1,227 visits.

• 80.8% of the dermatologists were satisfied/very satisfied with the ADRS and 75% outlined the interest of the ADRS to allow them to discuss the risk of depression more easily with their patients; 82.7% identified its use in clinical practice as easy/very easy.

• The ADRS was well acceptable for 93.8% of adolescents.

• Overall findings suggest the value of implementing the ADRS in dermatology practice, optimizing the monitoring of patients and the good use of isotretinoin.